110 related articles for article (PubMed ID: 2449841)
1. The activation of the contact system of human plasma by polysaccharide sulfates.
Silverberg M; Diehl SV
Ann N Y Acad Sci; 1987; 516():268-79. PubMed ID: 2449841
[No Abstract] [Full Text] [Related]
2. Inhibition of prekallikrein activation in human plasma by components of bovine plasma.
Weerasinghe KM; Kirby EP
Inflammation; 1992 Oct; 16(5):497-507. PubMed ID: 1428124
[TBL] [Abstract][Full Text] [Related]
3. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the rate of contact activation in human plasma.
Brunnée T; Coy G; Reddigari SR; Silverberg M
Agents Actions Suppl; 1992; 38 ( Pt 2)():231-6. PubMed ID: 1462830
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis.
Hauert J; Nicoloso G; Schleuning WD; Bachmann F; Schapira M
Blood; 1989 Mar; 73(4):994-9. PubMed ID: 2465792
[TBL] [Abstract][Full Text] [Related]
6. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate.
Tsuda H; Miyata T; Iwanaga S; Yamamoto T
Thromb Haemost; 1992 Apr; 67(4):440-4. PubMed ID: 1631792
[TBL] [Abstract][Full Text] [Related]
7. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.
Revak SD; Cochrane CG; Bouma BN; Griffin JH
J Exp Med; 1978 Mar; 147(3):719-29. PubMed ID: 632748
[TBL] [Abstract][Full Text] [Related]
8. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
Jespersen J; Kluft C
Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
[TBL] [Abstract][Full Text] [Related]
9. Prekallikrein activation and kallikrein inactivation in human plasma.
van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
[No Abstract] [Full Text] [Related]
10. Factor XII: form determines function.
de Maat S; Maas C
J Thromb Haemost; 2016 Aug; 14(8):1498-506. PubMed ID: 27282310
[TBL] [Abstract][Full Text] [Related]
11. The effect of beta 2-glycoprotein I on the dextran sulfate and sulfatide activation of the contact system (Hageman factor system) in the blood coagulation.
Schousboe I; Rasmussen MS
Int J Biochem; 1988; 20(8):787-92. PubMed ID: 3169363
[TBL] [Abstract][Full Text] [Related]
12. A new prekallikrein activator in human plasma which differs from Hageman factor and its fragments.
Webster ME; Stella RC; Villa ML; Toffoletto O
Adv Exp Med Biol; 1979; 120B():53-9. PubMed ID: 517247
[No Abstract] [Full Text] [Related]
13. Dextran sulfate-dependent fibrinolysis in whole human plasma.
Miles LA; Rothschild Z; Griffin JH
J Lab Clin Med; 1983 Feb; 101(2):214-25. PubMed ID: 6185600
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus gallolyticus subsp. gallolyticus endocarditis isolate interferes with coagulation and activates the contact system.
Isenring J; Köhler J; Nakata M; Frank M; Jans C; Renault P; Danne C; Dramsi S; Kreikemeyer B; Oehmcke-Hecht S
Virulence; 2018 Jan; 9(1):248-261. PubMed ID: 29072555
[TBL] [Abstract][Full Text] [Related]
15. Studies on contact activation: effects of surface and inhibitors.
Cameron CL; Fisslthaler B; Sherman A; Reddigari S; Silverberg M
Med Prog Technol; 1989; 15(1-2):53-62. PubMed ID: 2530427
[TBL] [Abstract][Full Text] [Related]
16. Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII.
Schousboe I; Rasmussen MS; Lintner R
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):503-9. PubMed ID: 7841305
[TBL] [Abstract][Full Text] [Related]
17. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
18. Dissemination of contact activation in plasma by plasma kallikrein.
Cochrane CG; Revak SD
J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
[TBL] [Abstract][Full Text] [Related]
19. Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin.
Cornelius RM; Sanchez J; Olsson P; Brash JL
J Biomed Mater Res A; 2003 Nov; 67(2):475-83. PubMed ID: 14566788
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional characterization of factor XII.
Tans G; Rosing J
Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
